Healthcare -
Biotechnology - NASDAQ - US
$ 1.33
-13.6 %
$ 111 M
Market Cap
-0.46
P/E
EDIT - REVENUE
Revenue EDIT - Editas Medicine, Inc.
32.3 M
LAST VALUE
28.04%
2 YEAR CAGR
9.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR